COIOSDeep risk insights through multi-disciplinary research across the globe
cars parked on the side of the road during daytime
Item new Peer-reviewed Added

Opioid use disorder medication in residential treatment modelled for Massachusetts

A model found offering opioid use disorder medication in Massachusetts residential centres, with outpatient linkage, cost $40,195 per QALY gained.

A cohort state-transition model simulated Massachusetts residential centres offering medications for opioid use disorder (OUD), or MOUD. Offering MOUD in all centres raised MOUD time by 36% and prevented 5 overdose deaths per 10,000 at one year. Adding outpatient linkage for all discharged patients was the preferred strategy, at $40,195 per QALY gained. Statewide, it prevented 2.64 overdose deaths per 10,000 people with OUD over 10 years, a 0.40% reduction. Providing MOUD in residential treatment had a five-year budget impact of $9.65 million. The results are modelled, and some centres might close rather than offer MOUD.

Why it is interesting: The model costs a medication that only a small fraction of residential centres currently offer. Per-person gains are small, yet linking all discharges to outpatient care cost less than offering MOUD alone.

Source
Addiction, 2 November 2026
Paper
Impact of improved access to medications for opioid use disorder in residential treatment
Authors
Castry M, Zwick H, Barocas J, Meisel ZF, Walley AY, Linas BP
DOI
10.1111/add.70630
Type
Peer-reviewed article
Design
Cohort state-transition simulation model (closed and open cohort), Massachusetts opioid use disorder population, four policy strategies, lifetime and 10-year horizons, 2024 USD
Verdict
New finding
Driver
Value in health
Driver
Alcohol and drug use
Free full text
Free to read at the publisher

Other drivers in Data, models and systems